Abstract

Following the publication of the above article, an interested reader drew to the authors' attention that an error was made in the assembly of the data panels shown in Fig.4A. The 'NC' and 'FoxO3a‑KD' panels (specifically, the upper left margins of the three 'NC' data panels and the lower right margins of the three 'FoxO3a‑KD' panels) contained overlapping data. The authors were able to consult their original data, and realized that errors had occurred inadvertently during the figure compilation process. The revised version of Fig.4A, featuring the corrected data panels for the 'NC' experiments, is shown opposite. The authors have confirmed that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum. Furthermore, they apologize to the readership of the Journal for any inconvenience caused. [the original article was published in Oncology Reports 37: 2391‑2397, 2017; DOI: 10.3892/or.2017.5459].

Highlights

  • FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β‐catenin nuclear accumulation

  • The authors have confirmed that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum

  • They apologize to the readership of the Journal for any inconvenience caused

Read more

Summary

Introduction

FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β‐catenin nuclear accumulation

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.